Tirzepatide and Kidney Protection in Obesity: Unanswered Questions.

Explores the renal protective benefits of next-generation dual GIP/GLP-1 receptor agonists in patients with diabetic kidney disease.

Source

J Am Soc Nephrol

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.